Dan Karlin - Dec 21, 2022 Form 4 Insider Report for Mind Medicine (MindMed) Inc. (MNMD)

Role: Chief Medical Officer
Signature: /s/ Carrie Liao, Attorney-in-Fact
Stock symbol: MNMD
Transactions as of: Dec 21, 2022
Transactions value $: -$3,258
Form type: 4
Date filed: 12/22/2022, 03:32 PM
Previous filing: Oct 27, 2022
Next filing: Mar 2, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MNMD	Common Shares	Sale	-$3.26K	-1.21K	-0.46%	$2.69	264K	Dec 21, 2022	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Common Shares sold to satisfy withholding tax obligations upon the delivery of Common Shares for restricted stock units that vested on November 24, 2022 and November 26, 2022, pursuant to sell-to-cover elections.
F2	The reported price is a weighted average sales price. This represents the price in United States Dollars using the conversion rate on December 21, 2022. These shares were sold in multiple transactions on December 21, 2022 at prices ranging from $3.65 to $3.67 CAD Dollars. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Content

Common Shares sold to satisfy withholding tax obligations upon the delivery of Common Shares for restricted stock units that vested on November 24, 2022 and November 26, 2022, pursuant to sell-to-cover elections.

The reported price is a weighted average sales price. This represents the price in United States Dollars using the conversion rate on December 21, 2022. These shares were sold in multiple transactions on December 21, 2022 at prices ranging from $3.65 to $3.67 CAD Dollars. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.